This article is more than 5 years old. Information may no longer be current.

Bausch + Lomb announces launch of Incise microincision IOL in Europe

Issue: June 2013

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Bausch + Lomb announced the European launch of its new Incise microincision IOL to enable less obtrusive surgery with prompt visual recovery.

The Incise lens was designed to diminish posterior capsular opacification, a long-term postoperative complication that clouds patient vision.

“The new Incise lens is the latest innovation from Bausch + Lomb, designed to meet the needs of both customers and patients. The combination of the enhanced material in the IOL and the new Viscoject Bio injector enables surgeons to deliver predictable injection performance and optical quality for sub-2-mm delivery,” Cal Roberts, MD, executive vice president and chief medical officer, said in a press release.